A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2012
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 22 Oct 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 22 Oct 2012 Planned End Date changed from 1 Jul 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 10 Aug 2012 New trial record